Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility

Journal of Human Genetics

Volumn 56, Issue 7, 2011, Pages 496-502

  Xie, Chunmei C ^a   Lu, Lingyi ^a   Sun, Jielin ^a   Zheng, S Lilly ^a   Isaacs, William B ^b   Gronberg, Henrik ^c   Xu, Jianfeng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

co segregation; family based association; population based association; prostate cancer; PTEN; sequencing

Indexed keywords

5' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FAMILIAL CANCER; GENE; GENE DELETION; GENE FREQUENCY; GENE SEGREGATION; GENE SEQUENCE; GENETIC MARKER; GENETIC VARIABILITY; GERM LINE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PENETRANCE; PROSTATE CANCER; PTEN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE;

EID: 79960750629     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2011.48     Document Type: Article

References (27)

1. Di Cristofano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100, 387-390 (2000).
2. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. PTEN is essential for embryonic development and tumor suppression. Nature Genet. 19, 348-355 (1998). (Pubitemid 28357906)
3. Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J. et al. Prostate-specific deletion of the murine PTEN tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 4, 209-221 (2003) (Pubitemid 37163835)
4. Abate-Shen, C., Banach-Petrosky, W. A., Sun, X., Economides, K. D., Desai, N., Gregg, J. P. et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 63, 3886-3890 (2003). (Pubitemid 36917899)
5. Halvorsen, O., Haukaas, S. A. & Akslen, L. A. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin. Cancer Res. 9, 1474-1479 (2003). (Pubitemid 36418404)
6. Dong, J. T., Li, C. L., Sipe, T. W. & Frierson, H. F Jr. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients. Clin. Cancer Res. 7, 304-308 (2001). (Pubitemid 32183034)
7. Simpson, L. & Parsons, R. PTEN: life as a tumor suppressor. Exp. Cell Res. 264, 29-41 (2001). (Pubitemid 32989079)
8. Schmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J. et al. Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. Int. J. Cancer 120, 1284-1292 (2006).
9. Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005). (Pubitemid 40966196)
10. Verhagen, P. C., Duijin, P. W.,Hermans,K.G., Looijenga, L.H., VanGurp, R. J.,Stoop, H. et al. The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion. J. Pathol. 208, 699-707 (2006).
11. Witte, J. S., Goddard, K. A., Conti, D. V., Elston, R. C., Lin, J., Suarez, B. K. et al. Genomewide scan for prostate cancer-aggressiveness loci. Am. J. Hum. Genet. 67, 92-99 (2000). (Pubitemid 30481547)
12. Gibbs, M., Stanford, J. L., Jarvik, G. P., Janer, M., Badzioch, M., Peters, M. A. et al. A genomic scan of families with prostate cancer identifies multiple regions of interest. Am. J. Hum. Genet. 67, 100-109 (2000). (Pubitemid 30481548)
13. Cooney, K. A., Tsou, H. C., Petty, E. M., Miesfeldt, S., Ping, X. L., Gruener, A. C. et al. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer. Clin. Cancer Res. 5, 1387-1391 (1999). (Pubitemid 29282943)
14. Forrest, M. S., Edwards, S. M., Hamoudi, R. A., Dearnaley, D. P., Arden-Jones, A., Dowe, A. et al. No evidence of germline PTEN mutations in familial prostate cancer. J. Med. Genet. 3, 210-212 (2000). (Pubitemid 30245916)
15. Bar-Shira, A., Matarasso, N., Rosner, S., Bercovich, D., Matzkin, H. & Orr-Urtreger, A. Mutation screening and association study of the Candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6. Prostate 66, 1052-1060 (2006). (Pubitemid 43939208)
16. Haiman, C. A., Stram, D. O., Cheng, I., Giorgi, E. E., Pooler, L., Penney, K. et al. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Cancer Epidemiol. Biomarkers. Prev. 15, 1021-1025 (2006). (Pubitemid 43823533)
17. Xu, J., Gillanders, E. M., Isaacs, S. D., Chang, B. L., Wiley, K. E., Zheng, S. L. et al. Genome-wide scan for prostate cance rsusceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 57, 320-325 (2003). (Pubitemid 37487077)
18. Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G. et al. Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med. 358, 910-919 (2008). (Pubitemid 351397090)
19. Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S. et al. Genomewide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007). (Pubitemid 46676108)
20. Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310-315 (2008). (Pubitemid 351311773)
21. Amundadottir, L. T., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B. A. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652-658 (2006). (Pubitemid 43927306)
22. Duggan, D., Zheng, S L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F. et al. Two genome wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Natl Cancer Inst. 99, 1836-1844 (2007). (Pubitemid 351767196)
23. Liu, W., Sun, J., Li, G., Zhu, Y., Zhang, S., Kim, S. T. et al. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res. 69, 2176-2179 (2009).
24. Laird, N. M., Horvath, S. & Xu, X. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 19, S26-42 (2000).
25. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007). (Pubitemid 47014502)
26. McCarroll, S. A., Kuruvilla, F. G., Korn, J. M., Cawley, S., Nemesh, J., Wysoker, A. et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet. 40, 1166-1174 (2008).
27. Yoshimoto, M., Joshua, A. M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Ludkovski, O. et al. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cnacer is associated with a favorable outcome. Mod. Pathol. 23, 1-10 (2008).